Oncolytics Biotech Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -3.87 | -100% |
| P/S |
|
0 | 33.76 | -100% |
|
|
| P/BV |
|
4.16 | 4.82 | -13.68% |
|
|
| P/FCF |
|
-6.01 | 60.98 | -109.85% |
|
|
| Ev/Ebitda |
|
-2.5 | -22.31 | -88.78% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-2.94 | 68.78 | -104.27% |
|
|
| E/P |
|
-0.1624 | 0.0178 | -1013.71% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 5.1 | -100% | -1623.49 | -100% |
| ROE |
|
-100.69 | 9.61 | -1148.14% |
|
|
| ROA |
|
-71.49 | 0.3359 | -21382.45% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-122.6 | 15.48 | -892.13% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0127 | -3.69 | -99.66% | -0.0157 | -19.21% |
| Nеt Debt/Ebitda |
|
0.9318 | -3.44 | -127.09% |
|
|
| Debt/Ratio |
|
0.0109 | 0.1975 | -94.48% |
|
|
| Debt/Equity |
|
0.0158 | 1.55 | -98.98% |
|
|
| Debt/Net Income |
|
-0.0152 | 10.31 | -100.15% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5526 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.1053 | -100% | ||
| DSI |
|
0 | 0.2174 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0635 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.494 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5526 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
2222.78 | -56.89 | -4007.15% | ||
| Growth impulse Ebitda in 5 years |
|
343.61 | -53.14 | -746.61% | ||
| Growth impulse Net Income in 5 years |
|
-39.08 | -58.33 | -33% | ||
| Growth impulse FCF in 5 years |
|
42.87 | -49.48 | -186.64% | ||
| Growth impulse EPS in 5 years |
|
-55.87 | -32.41 | 72.39% |
IP Score
3.58/10
